Umeclidinium/Vilanterol (LABA/LAMA combination)
Treatment for Emphysema
Typical Dosage: 62.5 mcg umeclidinium / 25 mcg vilanterol once daily
Effectiveness
75%
Safety Score
65%
Clinical Trials
50
Participants
20K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
62.5 mcg umeclidinium / 25 mcg vilanterol once daily
Time to Effect
within 15 minutes
Treatment Duration
lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
12(Treat 12 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
40(Treat 40 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$6,000
Monitoring:$800
Side Effect Mgmt:$100
Total Annual:$6,900
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$65,000/QALY
QALYs Gained
0.25
Outcome-Based Costs
Cost per Responder
$9,200
Umeclidinium/Vilanterol (LABA/LAMA combination) Outcomes
for Emphysema
Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+75%
Common Side Effects
Upper respiratory tract infection
+9.5%
Nasopharyngitis
+7.5%
Headache
+5.5%
Cough
+3.5%
Dry mouth
+2.5%
Urinary tract infection
+2.5%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov